MRA-Funded Studies

StartMRA-Funded Studies

MRA-Funded Studies

The Medical University of Gdańsk is among the most successful institutions in securing funding from the Medical Research Agency (MRA). Below you can find the projects currently conducted within CWBK.

Current MANASKIN Use of dupilumab in the treatment of systemic mastocytosis.
Current MARFAN Evaluation of valsartan efficacy in children and young adults with aortic disease.
Current POLPHITT/POLSTS Clinical trial in children and adolescents with primary liver tumours.
Current ERICONS Early rituximab treatment in children with idiopathic nephrotic syndrome.
Current MSC Fibro (WHARTON) Assessment of mesenchymal stem cell therapy in interstitial lung diseases.
Current WAKE-IN Mechanical thrombectomy in stroke patients selected using MRI.
Current N-BURGUND Nivolumab combined with BGD chemotherapy in patients with Hodgkin lymphoma.
Current RAFTING Radiation-free therapy for early-stage Hodgkin lymphoma.
Current ADONIS-PCI Dual antithrombotic therapy with dabigatran and ticagrelor in patients with acute coronary syndrome and non-valvular atrial fibrillation undergoing percutaneous coronary intervention.
Current MeDMD Evaluation of metoprolol for the prevention of cardiomyopathy and cardiac death in patients with Duchenne muscular dystrophy.
Current STROACT Pharmacological reperfusion treatment of ischaemic stroke in patients receiving oral anticoagulants.
Current SERTRALINE Effects of sertraline on depressive and anxiety symptoms, endothelial dysfunction and biomarkers in patients with heart failure with preserved ejection fraction.
Current LEVOTAKO A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Levosimendan Therapy in Low Ejection Fraction Takotsubo Syndrome.
Current MULTIPREVENT Multimorbidity – personalised health prevention for adults.

Archive